VALCYTE

This brand name is authorized in United States. It is also authorized in Australia, Austria, Brazil, Canada, Croatia, Cyprus, Estonia, Finland, Hong Kong SAR China, Ireland, Italy, Lithuania, Malta, Mexico, Netherlands, Poland, Singapore, South Africa, Spain, Turkey, UK.

Active ingredients

The drug VALCYTE contains one active pharmaceutical ingredient (API):

1	Valganciclovir UNII 4P3T9QF9NZ - VALGANCICLOVIR HYDROCHLORIDE
	Valganciclovir is an L-valyl ester (prodrug) of ganciclovir. Ganciclovir is a synthetic analogue of 2'-deoxyguanosine and inhibits replication of herpes viruses in vitro and in vivo.
	Read more about Valganciclovir

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
J05AB14	Valganciclovir	J Antiinfectives for systemic use → J05 Antivirals for systemic use → J05A Direct acting antivirals → J05AB Nucleosides and nucleotides excl. reverse transcriptase inhibitors
Discover more medicines within J05AB14

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
AU	Pharmaceutical Benefits Scheme	10277X, 10306K, 6357N, 9569P, 9655E, 9675F
BR	Câmara de Regulação do Mercado de Medicamentos	529207001111317
CA	Health Products and Food Branch	02245777, 02306085
EE	Ravimiamet	1167713, 1268579, 1846403
ES	Centro de información online de medicamentos de la AEMPS	64829, 69760
FI	Lääkealan turvallisuus- ja kehittämiskeskus	086969
GB	Medicines & Healthcare Products Regulatory Agency	153550, 43392
HK	Department of Health Drug Office	51219, 65921
HR	Agencija za lijekove i medicinske proizvode	HR-H-673424468, HR-H-809762522
IE	Health Products Regulatory Authority	88596, 88639
IT	Agenzia del Farmaco	035739010
LT	Valstybinė vaistų kontrolės tarnyba	1004609, 1023760
MT	Medicines Authority	AA565/54701, AA565/54702, AA729/00702
MX	Comisión Federal para la Protección contra Riesgos Sanitarios	265M2002
NL	Z-Index G-Standaard, PRK	134708, 60429
PL	Rejestru Produktów Leczniczych	100215401, 100326589
SG	Health Sciences Authority	12393P
TR	İlaç ve Tıbbi Cihaz Kurumu	8682340179053, 8682340179060
US	FDA, National Drug Code	0004-0038, 0004-0039
ZA	Health Products Regulatory Authority	37/20.2.8/0296, 43/20.2.8/0433